Revvity (RVTY) Surpasses Q3 Earnings Estimates

Group 1: Earnings Performance - Revvity reported quarterly earnings of $1.18 per share, exceeding the Zacks Consensus Estimate of $1.14 per share, but down from $1.28 per share a year ago, representing an earnings surprise of +3.51% [1] - The company posted revenues of $698.95 million for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.15%, compared to $684.05 million in the same quarter last year [2] Group 2: Market Performance and Outlook - Revvity shares have declined approximately 11.4% since the beginning of the year, while the S&P 500 has gained 15.5% [3] - The current consensus EPS estimate for the upcoming quarter is $1.54 on revenues of $762.72 million, and for the current fiscal year, it is $4.87 on revenues of $2.85 billion [7] Group 3: Industry Context - The Medical Services industry, to which Revvity belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8] - The estimate revisions trend for Revvity was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, suggesting expected underperformance in the near future [6]